This module is appropriate for clinical staff who need to achieve competency with Intravesical administration of chemotherapy drugs such as Epirubicin.
The Antineoplastic Drug Administration Course (ADAC) supports health professionals develop the necessary knowledge and clinical skills to safely administer antineoplastic drugs via different routes, and handle related waste safely.
The Intravesical cytotoxic course includes: high-quality interactive scenarios, a simulated video demonstrating best practice, multiple choice and competency assessment to consolidate theory into practice
- Key contact: Ariane Araquel-Lacamiento
- Key contact: Jan Benzon Chan
- Key contact: SHARON DEO
- Key contact: Audrey Gandhi
- Key contact: Juan Paulo Gultiano
- Key contact: Daniela Iosep
| This course is appropriate for health professionals who are administering antineoplastic drugs in the non-cancer clinical setting to patients who do not have a cancer diagnosis |
|
- Editing Trainer: Donna Moorman
| This course is appropriate for both clinical and non clinical staff and may be the course for participants who only need to develop an understanding of the principles of safe handling and competency with this procedure but who will not be administering antineoplastic drugs. This course will be closing to new enrolments at midnight of the 31st December 2024. Go here to access the Updated National ADAC material |
|
- Key contact: Donna Moorman
|
This module is appropriate for clinical staff who need to develop competency with oral administration but will not be administering intravenous antineoplastic drugs. The Antineoplastic Drug Administration Course (ADAC) supports health professionals develop the necessary knowledge and clinical skills to administer antineoplastic drugs via different routes and handle related waste safely. ADAC uses eviQ content to develop education courses that are based upon the best and most comprehensive evidence available at the time of development. ADAC was developed by the Cancer Institute NSW and follows a strict governance process. The course includes high quality interactive scenario based eLearning guides, eQuizzes, supervised clinical practice, competency assessments and a clinical skills workshop to consolidate theory to practice. It is recommended that clinical participants meet the following prerequisites:
This course will be closing to new enrolments at midnight of the 31st December 2024. |
|
- Key Contact: Donna Moorman
|
This module is appropriate for clinical staff who need to develop competency with intravenous administration of antineoplastic drugs. The Antineoplastic Drug Administration Course (ADAC) supports health professionals develop the necessary knowledge and clinical skills to administer antineoplastic drugs via different routes and handle related waste safely. ADAC uses eviQ content to develop education courses that are based upon the best and most comprehensive evidence available at the time of development. ADAC was developed by the Cancer Institute NSW and follows a strict governance process. The course includes high quality interactive scenario based eLearning guides, eQuizzes, supervised clinical practice, competency assessments and a clinical skills workshop to consolidate theory to practice. It is recommended that clinical participants meet the following prerequisites:
This course will be closing to new enrolments at midnight of the 31st December 2024. |
|
- Key Contact: Donna Moorman
| This course is closed to new enrolments. For the updated versions please go here The ADAC Reassessment of clinical competency module is designed for registered nurses required to demonstrate continuing maintenance of clinical skills. The annual (or biannual - depending on local policy) reassessment of clinical competency uses standardised reassessment of clinical competency tools for a certain skills level i.e. either 1) Administration of oral antineoplastic drugs or 2) Administration of intravenous antineoplastic drugs. |
|
- Key Contact: Donna Moorman